To date, many case–control studies that have been carried out to investigate whether CXCR4 rs2228014 polymorphism is associated with the risk of cancer have yielded conflicting results,[15–25] which might partially own to the relatively small sample size of individual study, the different distributions of patients or controls, different cancer types, and the various methodologies. Here, CXCR4 is linked to cancer.